Devic’s Disease (Neuromyelitis Optica)
Keywords:
Neuromielitis optica, Devic’s disease, multiple sclerosisAbstract
The Neuromyelitis Optica is a diesmelinizante, autoimmune, idiopathic disease characterized by the presence of optic neuritis and acute myelitis, previously considered as a variant of multiple sclerosis, but today is classi ed as a completely separate entity, because of it is imnunopatologic features, resistance to treatment, and poor prognosis. We report a clinical case of a patient with a history of tetraparesis and blindness, progressive on set and sequential presentation, which was initially diagnosed with Multiple Sclerosis, but later due to the clinical manifestations, treatment resistance to glucocorticoids and ndings on MRI made it diagnosis of Neuromyelitis Optica.Metrics
References
Adamson J. 2012. Ferropenia y otras anemias hipoproloferativas Harrison principios de Medicina Interna. Mc Graw-Hill. México DF, México. 18 edición, cap 103 p. 844.
Alarcón T. 2010. Neuromielitis óptica un caso de revisión y literatura. Disponible en: http://hospitalalcivar.com/uploads/pdf/ NeuromielitisOptica.pdf. (Consultado enero 20.2014)
Baigent C.; Blackwell L.; Collins R.; Emberson J.; Godwin J.; Peto R.; Buring J.; Hennekens C.; Kearney P.; Meade T.; Patrono C.; Roncaglioni MC.; Zanchetti A. 2009. Aspirin in the primary and secondary prevention of a vascular disease: collaborative meta-analysis of individual participant data from randomized trials. The Lancet , 373 (9678): 1849-1860
Chiquete E.; Navarro-Bonnet J.; Ayala-Armas R.; Gutiérrez-Gutiérrez N.; Solórzano- Meléndez A.; Rodríguez-Tapia D. 2010. Neuromielitis óptica: actualización clínica. Revista Neurología, 51 (5): 289-294.
Dale Russell C. y Vincent Angela. 2010. Transverse myelitis. In ammatory and Autoimmune Disorders of the Nervous System in Children. Mac Keith Press. London, GBR. Capítulo 6 p. 97.
De Seze J. y Collongues, N. 20013. Novel advances in the diagnosis and treatment of neuromyelitis optica: is there a need to rede ne the gold standard?. Expert Review of Clinical Immunology 9 (10): 979-986.
Del Cura J. L.; Pedraza S.; Gayate A. 2010. Enfermedad in amatorio-desmelinizante del sistema nervioso central. Radiología Escencial Tomo II. Editorial medica Panamericana Madrid, España. Capítulo 86, p. 1214
Eckhard A.; Gleiser C.; Rask-Andersen H., Arnold H., Liu W., Mack A. 2012. Co- localisation of K.sub.ir 4.1 and AQP4 in rat and human cochleae reveals a gap in water channel expression at the transduction sites of endocochlear K+ recycling routes. Revista Cell and Tissue Research, 350 (1): 27-43.
Iglesias A.; Gil D.; Restrepo J.; Gamarra I. 2011. Historia de la enfermedad de Enfermedad de Devic. Revista Colombiana de Reumatología , 18 (4).
Jarius S.; Ruprecht, K.; Wildemann B.; Kuempfel, T.; Ringelstein M., et al., 2012. Contrasting disease patterns in seropositive and seronegative neuromyelitis optica: A multicentre study of 175 patients. Journal of Neuroin ammation, 9 (14).
Misu T.: Fujihara K.; Nakashima I.; Sato S.; Itoyoma Y. 2005. Intractable hiccup and nausea with periaqueductal lesions in neuromyelitis optica. Neurology, 65 (9): 1479-1482.
Pinzón A.; Echeverría T.; Rodríguez A. 2010. Neuromielitis Optica presentación de un caso. Revista Acta Médica Colombiana,
(1): 21-25
Scholz.; Erwin MüLler y Carl. 2012. Multiple Sclerosis: Causes, Diagnosis and Management . Immunology and Immune System Disorders. Nova Science Publishers, Inc. New York, USA. Capítulo 3 p. 69.
Stephen L.; Hauser y Douglas S. Goodin. 2012. Esclerosis Múltiple y Otras enfermedades diesmelinizante. Harrison principios de Medicina Interna. Mc Graw-Hill. México DF, México. 18 edición, p. 3395.
Sven Jarius y Brigitte Wildemann. AQP4 antibodies in neuromyelitis optica: diagnostic and pathogenetic relevance. 2010. Nature Reviews Neurology, 6 (7): 383-392.
Wingerchuk DM.; Hogancamp W.; Pitter C. O ́Brien y Brian C. 1999. The clinical course of neuromyelitis optica (Devic ́s syndrome). Neurology, 53:1107
Wingerchuk DM.; Lennon VA.; Pittock SJ.; Lucchinetti CF.; Weinshenker BG. 2006. Revised diagnostic criteria for neuromyelitis optica. Neurology, 66 (10): 1485-1489.
Wingerchuk DM.; Lucchinetti CF.; Lennon VA.; Pittock SJ.; Weinshenker BG. 2007. The spectrum of neuromyelitis optica. Lancet Neurology. 6: 805–815.
Downloads
Published
How to Cite
Issue
Section
License
Those authors who have publications with this journal, accept the following terms:
- After the scientific article is accepted for publication, the author agrees to transfer the rights of the first publication to the CEDAMAZ Journal, but the authors retain the copyright. The total or partial reproduction of the published texts is allowed as long as it is not for profit. When the total or partial reproduction of scientific articles accepted and published in the CEDAMAZ Journal is carried out, the complete source and the electronic address of the publication must be cited.
- Scientific articles accepted and published in the CEDAMAZ journal may be deposited by the authors in their entirety in any repository without commercial purposes.
- Authors should not distribute accepted scientific articles that have not yet been officially published by CEDAMAZ. Failure to comply with this rule will result in the rejection of the scientific article.
- The publication of your work will be simultaneously subject to the Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0)
